Table 1.
Demographic characteristicsa | N | Column % |
---|---|---|
Age at diagnosis (years) | ||
< 40 | 157 | 14.7 |
40 – 49 | 253 | 23.6 |
50 – 59 | 274 | 25.6 |
60 – 69 | 200 | 18.7 |
≥ 70 | 187 | 17.5 |
Year of diagnosis | ||
2006–07 | 167 | 15.6 |
2008–09 | 414 | 38.7 |
2010–2012 | 490 | 45.8 |
Race | ||
Black African | 964 | 90.0 |
White | 43 | 4.0 |
Coloured | 42 | 3.9 |
Indian or Asian | 18 | 1.7 |
Straight-line distance to hospital (km) | ||
< 5 | 183 | 17.1 |
5 – 9.9 | 299 | 27.9 |
10–19.9 | 242 | 22.6 |
20–29.9 | 188 | 17.6 |
30–39.9 | 61 | 5.7 |
≥ 40 | 98 | 9.6 |
Residential area | ||
Nearest area Farther areas: | ||
Soweto | 654 | 61.1 |
Orange Farm & Sebokeng | 123 | 11.5 |
Katlehong | 124 | 11.6 |
Vanderbijlpark | 36 | 3.4 |
Other | 134 | 12.5 |
Referral route to hospital | ||
Via: | ||
Primary health clinic | 243 | 49.3 |
Secondary hospitals | 107 | 21.7 |
Local doctor | 57 | 11.6 |
Self-referral | 86 | 17.5 |
Clinicopathologic Characteristics | N | Column % |
---|---|---|
Stage | ||
Stage I | 53 | 5.0 |
Stage II | 431 | 41.0 |
Stage III | 480 | 45.7 |
Stage IV | 87 | 8.3 |
Receptor Status | ||
ER+ and/or PR+ | 628 | 66.6 |
ER− and PR− | 315 | 33.4 |
HER2+ | 235 | 26.0 |
HER2− | 668 | 74.0 |
ER−/PR−/HER2− | 193 | 21.5 |
HIV status for 67% of women | ||
HIV positive | 132 | 18.4 |
HIV negative | 586 | 81.6 |
% (n) of each characteristic which was missing were 0% for age and distance (by definition of sample set) and for residential area and year of diagnosis, 1% (n=20) for stage, 12% (n=128 for ER and PR and 168 for HER2) for receptor status, 22% (n=231) for tumour size, 54% (n=578) for referral source, and 0.5% (n=4) for race.
Mean tumour size for all women was 40 mm (n=863).